Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms

Nature Reviews Cancer

Volumn 3, Issue 8, 2003, Pages 601-614

  Lamprecht, Sergio A ^a   Lipkin, Martin ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CARBON; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; DNA; FOLIC ACID; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; UVOMORULIN; VITAMIN D; ANTINEOPLASTIC AGENT;

ANIMAL MODEL; APOPTOSIS; CALCIUM INTAKE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DNA METHYLATION; HUMAN; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VITAMIN INTAKE; ANIMAL; BIOLOGICAL MODEL; COLON TUMOR; GENE EXPRESSION REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CALCIUM, DIETARY; COLONIC NEOPLASMS; FOLIC ACID; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 0041383927     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1144     Document Type: Review

References (146)

1. Potter, J. D. Colorectal cancer: molecules and populations. J. Natl Cancer Inst. 91, 916-932 (1999).
2. Kinzler, K. W. & Vogelstein, B. in The Genetic Basis of Human Cancer (eds Vogelstein, B. & Kinzler, K. W.) 583 -612 (McGraw-Hill, New York, 2001).
3. Lipkin, M., Reddy, B., Newmark, H. & Lamprecht, S. A. Dietary factors in human colorectal cancer. Annu. Rev. Nutr. 19, 545-586 (1999).
4. Milner, J. A., McDonald, S. S., Anderson, D. E. & Greenwald, P. Molecular targets for nutrients involved with cancer prevention. Nutr. Cancer 41, 1-16 (2001).
5. Holt, P. R., Wolper, C., Moss, S. F., Yang, K. & Lipkin, M. Comparison of calcium supplementation or low-fat dairy foods on epithelia]-cell proliferation and differentiation. Nutr. Cancer 41, 150-155 (2001).
6. Giovannucci, E. Epidemiologic studies of folate and colorectal neoplasia. J. Nutr. 132, 235OS-2355S (2002).
7. Choi, S.-W. & Mason, J. B. Folate status: effects on pathways of colorectal carcinogenesis. J. Nutr. 132, 2413S-2418S (2002). An incisive and comprehensive review that discusses folate modulation of colon carcinogenesis.
8. Mason, J. B. Nutritional chemoprevention of colon cancer. Semin. Gastrointest. Dis. 13, 143-153 (2002).
9. Lipkin, M. et al. Preclinical mouse models for cancer chemoprevention studies. Ann. NY Acad. Sci. 889, 14-19 (1999).
10. Risio, M. et al. Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res. 56, 4910-4916 (1996).
11. Newmark, H. L. et al. A western-style diet induces benign and malignant neoplasms in the colon of normal C57BL/6 mice. Carcinogenesis 22, 1871-1875 (2001). This study shows that a Western-style diet with decreased calcium, vitamin D and one-carbon donors induces colon neoplasms in normal mice without carcinogen exposure.
12. Berridge, M. J., Bootman, M. J. & Roderick, H. L. Calcium signalling: dynamics, homeostasis and remodelling. Nature Rev. Mol. Cell Biol. 4, 517-529 (2003).
13. Cullen, P. J. & Lockyer, P. L. Integration of calcium and ras signalling. Nature Rev. Mol. Cell Biol. 3, 339-348 (2002).
14. Lamprecht, S. A. & Lipkin, M. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann. NY Acad. Sci. 952, 73-85 (2001).
15. Newmark, H., Wargowich, M. J. & Bruce, W. R. Colon cancer and dietary fat, phosphate and calcium: a hypothesis. J. Natl Cancer Inst. 72, 1323-1325 (1984).
16. 2+ signaling requirements. J. Biochem. 337, 153-169 (1999).
17. Taylor, C. W. Controlling calcium entry. Cell 111, 767-769 (2002).
18. Brown, E. M. & MacLeod, R. J. Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 81, 239-297 (2001). An excellent review of the calcium-sensing receptor (CaR) and extracellular calcium signalling in cells of different lineages.
19. 2+-sensing receptor from bovine parathyroid. Nature 366, 575-580 (1993). This study describes the first cloning of CaR.
20. Pazianas, M. et al. Extracellular cation sensing by the enterocyte: prediction of a novel divalent cation "receptor". Biochem. Biophys. Res. Commun. 210, 948-953 (1995).
21. 2+-sensing receptors in intestinal epithelium. Am. J. Physiol. 273, C1168-C1175 (1997).
22. 2+-sensing receptor in rat intestine. Am. J. Physiol. 274, G122-G130 (1998).
23. Mitsuma, T. et al. Distribution of calcium sensing receptor in rats: an immunohistochemical study. Endocrin. Rev. 33, 55-59 (1999).
24. Cheng, S. X., Okuda, M., Hall, A. E., Geibel, J. P. & Hebert, S. C. Expression of calcium-sensing receptor in rat colonic epithelium: evidence for modulation of fluid secretion. Am. J. Physiol. 283, G240-G250 (2002).
25. Buchan, A. M., Squires, P. E., Ring, M. & Meloche, R. M. Mechanism of action of the calcium-sensing receptor in human antral gastrin cells. Gastroenterology 120, 1128-1139 (2001).
26. Kallay, E. et al. Calcium-dependent c-myc proto-oncogene expression and proliferation of CACO-2 cells: a role for a luminal extracellular calcium-sensing receptor. Biochem. Biophys. Res. Commun. 232, 80-83 (1997).
27. Sheinin, Y. et al. Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J. Histochem. Cytochem. 48, 595-602 (2000).
28. Kallay, E. et al. Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer Detect. Prev. 24, 127-136 (2000).
29. Chakrabarty, S., Radjendirane, V., Appelman, H. & Varani, J. Extracellular calcium and calcium-sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/TCF activation. Cancer Res. 63, 67-71 (2003). An interesting paper presenting evidence for the involvement of extracellular calcium and CaR in promoting the differentiation of colon cells and in suppressing β-catenin activation, which is a prominent signalling pathway involved in colon carcinogenesis.
30. Saxon, M. L., Zhao, X. & Black, J. D. Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ. J. Cell Biol. 126, 747-763 (1994).
31. Frey, M. R. et al. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J. Cell Biol. 151, 763-777 (2000).
32. Verstovsek, G., Byrd, A., Frey, M. R., Petrelli, N. J. & Black, J. D. Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. Gastroenterology 115, 75-85 (1998).
33. 2+-dependent protein kinases in human colon carcinomas. Cancer Res. 47, 2036-2039 (1987).
34. Kopp, R. et al. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res. 51, 205-210 (1991).
35. Cowell, H. E. & Garrod, D. R. Activation of protein kinase C modulates cell-cell and cell-substratum adhesion of a human colorectal carcinoma cell line and restores 'normal' epithelial morphology. Int. J. Cancer 80, 455-464 (1999).
36. Abraham, C. et al. Protein kinase Cα modulates growth and differentiation in Caco-2 cells. Gastroenterology 114, 503-509 (1998).
37. Scaglione-Sewell, B. et al. Decreased PKC-α expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res. 58, 1074-1081 (1998).
38. Klein, I. K. et al. Adenoma-specific alterations of protein kinase C isozyme expression in Apc min mice. Cancer Res. 60, 2077-2080 (2000).
39. Black, J. D. Protein kinase C isozymes in colon carcinogenesis: guilt by omission. Gastroenterology 120, 1868-1872 (2001).
40. Whitfield, J. F. Calcium signals and cancer. Crit. Rev. Oncog. 3, 55-90 (1992). An incisive review of calcium, which is aptly defined as 'the great signaller', at the heart of proliferation, differentiation and cancer.
41. Buras, R. R. et al. The effect of extracellular calcium on colonocytes: evidence for differential responsiveness based upon degree of cell differentiation. Cell Prolif. 28, 245-262 (1995).
42. 3 on the intracellular calcium gradient in mammalian colonic crypts. Cancer Lett. 127, 43-53 (1998).
43. Frey, M. R. et al. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21WAF1/CIP1 and p27KIP1 and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J. Biol. Chem. 272, 9424-9435 (1997).
44. Quaroni, A., Tian, J. Q., Seth, P. & Ap Rhys, C. p27(KIp1) is an inducer of intestinal epithelial cell differentiation. Am. J. Physiol. 279, C1045-C1057 (2000).
45. Deschenes, C., Vezina, A., Beaulieu, J.-F. & Rivard, N. Role of p27kip1 in human intestinal cell differentiation. Gastroenterology 120, 423-438 (2001).
46. El-Diery, W. S. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910-2919 (1995).
47. Polyak, K., Hamiton, S. R., Vogelstein, B. & Kinzler, K. W. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am. J. Pathol. 149, 381-387 (1996).
48. WAF1/CIP1 gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a western-style high-risk diet by altering cell maturation in the intestinal mucosa. Cancer Res. 61, 565-569 (2001). This incisive study describes the intestinal tumour-promoting effect of a Western-style diet in knockout mice deficient in Waf1, which is an important 'guardian' of the cell cycle.
49. McNeil, S. E., Hobson, S. A., Nipper V. & Rodland, K. D. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J. Biol. Chem. 273, 1114-1120 (1998).
50. Kifor, O. et al. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am. J. Physiol. 260, F291-F302 (2001).
51. Houde, M. et al. Intestinal epithelial cell differentiation involves activation of p38 mitogen-activated protein kinase that regulates the homeobox transcription factor CDX2. J. Biol. Chem. 276, 21885-21894 (2001).
52. Lorentz, O. et al. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J. Cell Biol. 139, 1553-1565 (1997).
53. Gianani, R. et al. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum. Pathol. 32, 119-125 (2001).
54. Gelebart, P. et al. Expression of endomembrane calcium pumps in colon and gastric cancer cells. J. Biol. Chem. 277, 26310-26320 (2002). An interesting paper showing that expression of SERCA3 is lost in colon cancer cells, in agreement with the observation that SERCAs have a determining role in cell differentiation.
55. Hajnoczky, G., Davies, E. & Madesh, M. Calcium signaling and apoptosis. Biochem. Biophys. Res. Commun. 304, 445-454 (2003).
56. Penham, I. D., Liang, R. L., Bode, J., Eastwood, M. D. & Arends, M. J. Dietary calcium supplementation increases apoptosis in the distal murine colonic epithelium. J. Clin. Pathol. 53, 302-307 (2000).
57. Hardungham, G. E., Chawia, S., Johnston, C. M. & Bading, H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260-265 (1997).
58. Studzinski, G. P., McLane, H. A. & Uskokovic, M. R. Signaling pathways for vitamin-D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit. Rev. Eukaryot. Gene Expr. 3, 279-312 (1993).
59. Ylikomi, T. et al. Antiproliferative action of vitamin D. Vitam. Horm. 64, 357-405 (2002).
60. Haussler, M. R. et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Metab. 13, 325-349 (1998).
61. Pike, J. W. in Vitamin D (eds Feldman, F., Glorieux, F. H. & Pike, J. W.) 105-125 (Academic Press, New York, 1997).
62. Sutton, A. M. L. & MacDonald, P. N. Vitamin D: More than a 'bona-a-fide' hormone. Mol. Endocrinol. 17, 777-791 (2003).
63. Lointier, P. et al. Specific receptor for 1.25 dihydroxyvitamin D3 (1.25 DR) and human colorectal carcinogenesis. Anticancer Res. 9, 1921-1924 (1989).
64. Lointier, P. et al. 1.25 dihydroxyvitamin D3 receptors and human colon adenocarcinoma. Br. J. Surg. 78, 435-439 (1991).
65. Meggouh, F., Lointier P. & Saez, S. Sex steroid and 1.25 dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res. 51, 1227-1233 (1991).
66. Frampton, R. J. et al. Presence of 1.25 dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res. 42, 1116-1119 (1982).
67. Brehier, A. & Thomasset, M. Human colon cell line HT-29 characterization of 1.25 dihydroxyvitamin D3 receptor and induction of differentiation by the hormone. J. Steroid Biochem. 29, 265-270 (1988).
68. Shabahang, M. et al. 1.25 dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res. 53, 3712-3718 (1993).
69. Sheinin, Y. et al. In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor expression. Virch. Arch. 437, 501-507 (2000).
70. 3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66, 287-292 (2001).
71. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis 13, 2293-2298 (1992).
72. 2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 2, 3043-3053 (1988).
73. Yanagisawa, J. et al. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321 (1999). An elegant paper showing the cross-talk between vitamin D and the TGF-β signalling pathway.
74. Canaff, L. & Hendy, G. N. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1.25-dihydroxyvitamin D. J. Biol. Chem. 277, 30337-30350 (2002). An interesting publication reporting that CaR is transcriptionally regulated by vitamin D.
75. Auvinen, M. et al. Transcriptional regulation of ornithine decarboxylase by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc. Int. J. Biochem. Cell Biol. 35, 469-521 (2003).
76. Jacoby, R. F. et al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc-mutant Min mouse adenomas, and selective toxicity against Apc-mutant embryos. Cancer Res. 60, 1864-1870 (2000).
77. Makishima, M. et al. Vitamin D receptor as an intestinal bile acid sensor. Science 296, 1313-1316 (2002). This work describes how the vitamin-D receptor 'senses' the presence of lithocholic acid, a potential pro-carcinogenic bile acid, and detoxifies it.
78. Thummel, K. E. et al. Transcriptional control of intestinal cytochrome P4503A by 1 α,25-dihydroxy vitamin D3. Mol. Pharmacol. 60, 1399-1406 (2001).
79. Kato, S. The function of vitamin D receptor in vitamin D action. J. Biochem. 127, 717-722 (2000).
80. Kallay, E. et al. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22, 1429-1435 (2001). These findings emphasize the importance of the vitamin-D receptor in protecting the colon mucosa against carcinogenesis.
81. 3. Mol. Cell. Endocrinol. 197, 1-13 (2002).
82. Norman, A. W., Olivera, C. J., Barreto Silva, F. R. M. & Bishop, J. E. A specific binding protein/receptor for 1 α,25-dihydroxyvitamin D3 is present in an intestinal caveolae membrane fraction. Biochem. Biophys. Res. Commun. 298, 414-419 (2002).
83. Lieberherr, M., Grosse, B., Duchambon, P. & Drueke, T. A functional cell-surface type receptor is required for the early action of 1.25-dihydroxyvitamin D on the phosphoinositide metabolism in rat enterocytes. J. Biol. Chem. 264, 20403-20406 (1989).
84. Kim, K. E. & Brasitus, T. A. The role of vitamin D in normal and pathologic processes in the colon. Curr. Opin. Gastroenterol. 17, 72-77 (2001).
85. Erben, R. G. et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol. Endocrinol. 16, 1524-1537 (2002).
86. Gurlek, A., Pittelkow, M. R. & Kumar, R. Modulation of growth factor/cytokine synthesis and signaling by 1 α,25-dihydroxyvitamin D3: implications in cell growth and differentiation. Endocrine Rev. 23, 763-786 (2002).
87. Wu, Y., Craig, T. A., Lutz, W. H. & Kumar, R. Identification of 1 α,25-dihydroxyvitamin D3 response elements in the human transforming growth factor β2 gene. Biochemistry 38, 2654-2660 (1999).
88. Yanagi, Y. et al. Positive and negative modulation of vitamin D receptor function by transforming growth factor-β signaling through Smad proteins. J. Biol. Chem. 274, 12971-12974 (1999).
89. 3. Am. J. Physiol. 283, G864-G874 (2002).
90. Scaglione-Sewell, B. A. et al. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting Cdk2 and Cdk6: roles of cyclin E, p21Waf1 and p27Kip1. Endocrinology 141, 3931-3939 (2000).
91. Skjode Jensen, S., Winkel Madsen, M., Lukas, J., Binderup, L. & Bartek, J. Inhibitory effects of 1.25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery. Mol. Endocrinol. 15, 1370-1380 (2001).
92. Arber, N. et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110, 669-674 (1996).
93. Zhang, T. et al. Concurrent overexpression of cyclin.D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res. 57, 169-175 (1997).
94. Shinozaki, H. et al. Cyclin D1 expression in the intestinal mucosa and tumors of Apc1638N mice. Anticancer Res. (in the press). [AU: any update?]
95. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154, 369-388 (2001). Convincing data showing that the differentiation-inducing action of vitamin D depends, at least partly, on the inhibition of inappropriate β-catenin expression.
96. Vandewalle, B., Wattez, N. & Lefebvre, J. Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT-29 cells: possible implication of intracellular calcium. Cancer Lett. 97, 99-106 (1995).
97. Diaz, G. D., Paraskeva, C., Thomas, M. G., Binderup, L. & Hague, A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 60, 2304-2312 (2000).
98. Guzey, M., Kitada, S. & Reed, J. C. Apoptosis induction by 1 α,25-dihydroxyvitamin D3 in prostate cancer. Mol. Cancer Ther. 1, 667-677 (2002).
99. Potter, J. D. Methyl supply, methyl metabolizing enzymes and colorectal neoplasia. J. Nutr. 132, 2410S-2412S (2002).
100. Choi, S.-W. & Mason, J. B. Folate and carcinogenesis: an integrated scheme. J. Nutr. 13, 129-132 (2000).
101. Jubb, A. M., Bell, S. M. & Quirke, P. Methylation and colorectal cancer. J. Pathol. 195, 111-134 (2001).
102. Robertson, K. D. & Wolffe, A. P. DNA methylation in health and disease. Nature Rev. Genet. 1, 11-19 (2000).
103. Duthie, S. J., Narayanan, S., Brand, G. M. Pirie, L. & Grant, G. Impact of folate deficiency on DNA stability. J. Nutr. 132, 2444S-2449S (2002).
104. Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92 (1983).
105. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M. & Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 142-196 (1998).
106. Costello, J. F. & Plass, C. Methylation matters. J. Med. Genet. 38, 285-303 (2001).
107. Fruhwald, M. C. & Plass, C. Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential. Mol. Genet. Metab. 75, 1-16 (2002).
108. Esteller, M. & Herman, J. G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 196, 1-7 (2002).
109. Bariol, C. et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am. J. Pathol. 162, 1361-1371 (2003).
110. Feinberg, A. & Vogelstein, B. Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111, 47-54 (1983).
111. Brown, T. A. Genomes (Wiley-Liss, USA, 1999).
112. Chen, R. Z., Petterson, V., Beard, C., Jackson-Grusby, L. & Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89-93 (1998).
113. Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489-492 (2003). References 112 and 113 provide solid evidence that DNA hypomethylation results in increased mutation rates, chromosome instability and neoplasia.
114. Rhee, I, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556 (2002). Interesting results that indicate redundancy of DNA methyltransferases in human cells.
115. Blount, B. C. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl Acad. Sci. USA 94, 3290-3295 (1997).
116. Choi, S.-W., Kim, Y.-I., Weitzel, J. N. & Mason, J. B. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 43, 93-99 (1998).
117. Cravo, M. L. et al. Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am. J. Gastroenterol. 93, 2060-2064 (1998).
118. Duthie, S. J., Narayanan, S., Blum, S., Pirie, L. & Brand, G. M. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excition repair in immortalized normal human colon epithelial cells. Nutr. Cancer 37, 245-251 (2000).
119. Nensey, Y. M., Arlow, F. L. & Majumdar, A. P. N. Aging increased responsiveness of colorectal mucosa to carcinogen stimulation and protective role of folic acid. Dig. Dis. Sci. 40, 396-401 (1995).
120. Biasco, G. et al. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol. Biomark. Prev. 6, 469-471 (1997).
121. Khosraviani, K., Weir, H. P., Hamilton, P., Moorehead, J. & Williamson, K. Effect of folate supplementation on mucosal cell proliferation in high-risk patients for colon cancer. Gut 51, 195-199 (2002).
122. Lamprecht, S. A. & Lipkin, M. Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis 23, 1777-1780 (2002).
123. Jaszewski, R. et al. Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines. Am. J. Physiol. 277, C1142-C1148 (1999).
124. Song, J., Medline, A., Mason, J. B., Gallinger, S. & Kim, Y.-I. Effects of dietary folate on intestinal tumorigenesis in the Apc Min mouse. Cancer Res. 60, 5434-5440 (2000).
125. -1- mice. Cancer Res. 60, 3191-3199 (2000).
126. Kim, Y.-I. et al. Exon-specific DNA hypomethylation of the p53 gene of the rat colon induced by dietary folate. Modulation by dietary folate. Am. J. Pathol. 149, 1129-1137 (1996).
127. Kim, Y.-I. et al. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology 119, 151-161 (2000).
128. Sohn, K.-J. et al. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 24, 81-90 (2003).
129. Le Leu, R. K., Young, G. P. & Mointosh, G. H. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21, 2261-2265 (2000).
130. Lu, S., Hoestje, S. M., Choo, E. & Epner, D. E. Induction of caspase-dependent and -independent apoptosis in response to methionine restriction. Int. J. Oncol. 22, 415-420 (2003).
131. Fuchs, C. S. et al. The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol. Biomark. Prev. 11, 227-234 (2002).
132. Konings, E. J M., Goldbohm, R. A., Brants, H. A., Saris, W. H. & van den Brandt, P. A. Intake of dietary folate vitamers and risk of colorectal carcinoma: results from The Netherlands Cohort Study. Cancer 85, 1421-1433 (2002).
133. Pufulete, M. et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenomas and cancer: a case control study. Gastroenterology 124, 1240-1248 (2003).
134. Ma, J. et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57, 1098-1102 (1997). The first paper to report that folate-replete individuals homozygous for a common polymorphic variant of MTHFR have half the risk of colon cancer compared with either the wild-type or heterozygous phenotypes.
135. Kim, Y.-I. Methylenetetrahydrofolate polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis Nutr. Rev 58, 205-217 (2002).
136. Chen, J. et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56, 4862-4864 (1996).
137. Cravo, M. L. et al. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur. J. Cancer Prev. 3, 473-479 (1994).
138. Lashner, B. A., Provencher, K. A., Seidner, D. L., Knesebeck, A. & Brzezinski, A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112, 29-32 (1997).
139. Lashner, B. A., Heidenreich, P. A., Su, G. L., Kane, S. V. & Hanauer, S. B. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case control study. Gastroenterology 97, 255-259 (1989).
140. Gupta, R. A. & DuBois, R. N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev. Cancer 1, 11-21 (2001).
141. 2+ store release. J. Biol. Chem. 273, 21267-21275 (1998).
142. 2+-sensing receptor (CaR) modulates functional interaction of G proteins with the CaR cytoplasmic tail. J. Biol. Chem. 277, 50543-50549 (2002).
143. 2+-sensing receptor require negative feedback by protein kinase C. J. Biol. Chem. 277, 46871-46876 (2002).
144. Lucock, M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 71, 121-138 (2000).
145. Donnelly, J. G. Folic acid. Crit. Rev. Clin. Lab. Sci. 38, 183-223 (2001).
146. Van den Veyver, I. B. Genetic effects of methylation diets. Annu. Rev. Nutr. 22, 255-282 (2002).